Boston Scientific Corp (BSX)
Debt-to-capital ratio
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — |
| Total stockholders’ equity | US$ in thousands | 21,770,000 | 19,282,000 | 17,574,000 | 16,623,000 | 15,327,000 |
| Debt-to-capital ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2024 calculation
Debt-to-capital ratio = Long-term debt ÷ (Long-term debt + Total stockholders’ equity)
= $—K ÷ ($—K + $21,770,000K)
= 0.00
Boston Scientific Corp's debt-to-capital ratio has consistently been 0.00 from December 31, 2020, to December 31, 2024. This indicates that the company has not used debt as a significant part of its capital structure during these years. A debt-to-capital ratio of zero suggests that the company's capital is primarily financed by equity rather than debt. This can be viewed positively as it signifies a lower financial risk and less financial leverage. However, it's essential to consider the industry norms and the company's growth and expansion plans to understand the rationale behind this low debt-to-capital ratio and its implications for the company's financial health and strategic positioning.
Peer comparison
Dec 31, 2024